Please login to the form below

Not currently logged in
Email:
Password:

intepirdine

This page shows the latest intepirdine news and features for those working in and with pharma, biotech and healthcare.

Axovant drops last ‘legacy’ drug to focus on gene therapies

Axovant drops last ‘legacy’ drug to focus on gene therapies

The decision to scrap nelotanserin comes after Axovant’s Alzheimer’s disease candidate intepirdine joined the chorus of failed drug candidates in that indication, and draws a line under the

Latest news

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics